Significance of circulatory DPP4 activity in metabolic diseases

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-6551|70|2|112-119

ISSN： 1521-6543

Source： IUBMB LIFE, Vol.70, Iss.2, 2018-02, pp. : 112-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules

By Aroor Annayya   Zuberek Marcin   Duta Cornel   Meuth Alex   Sowers James R.   Whaley-Connell Adam   Nistala Ravi  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 780-780

MDPI

Access to resources Recommend Favorite

Novel 4‐Heteroaryl‐Antipyrines as DPP‐IV Inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 5, 2015-11 ,pp. : 1292-1303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lysophosphatidylinositol Signalling and Metabolic Diseases

By Arifin Syamsul A.   Falasca Marco  

Metabolites, Vol. 6, Iss. 1, 2016-01 ,pp. : 6-6

MDPI

Access to resources Recommend Favorite

RAMEDIS: The Rare Metabolic Diseases Database

By Töpel Thoralf  

Applied Bioinformatics, Vol. 5, Iss. 2, 2006-01 ,pp. : 115-118

Adis International

Access to resources Recommend Favorite

Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases

By Jung Tae Woo   Choi Kyung Mook  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 192-192

MDPI

Access to resources Recommend Favorite